Pretreatment with AQP4 inhibitor TGN-020 significantly reduced focal cerebral ischemia induced brain edema (Igarashi et al., 2011) whereas bumetanide was shown to attenuate brain edema after traumatic brain injury (Hui et al., 2016). This evidence concerns the gene AQP4 and brain injury.